(Q36734736)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17297466%20AND%20SRC:MED&resulttype=core&format=json

25 December 2019

review article

1 reference

title

Cell-specific responses to loss of cyclin-dependent kinases (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17297466%20AND%20SRC:MED&resulttype=core&format=json

25 December 2019

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17297466%20AND%20SRC:MED&resulttype=core&format=json

25 December 2019

Philipp Kaldis

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17297466%20AND%20SRC:MED&resulttype=core&format=json

25 December 2019

author name string

C Berthet

series ordinal

1

1 reference

16 August 2017

P Kaldis

series ordinal

2

1 reference

16 August 2017

language of work or name

English

0 references

publication date

5 February 2007

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17297466%20AND%20SRC:MED&resulttype=core&format=json

25 December 2019

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17297466%20AND%20SRC:MED&resulttype=core&format=json

25 December 2019

volume

26

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17297466%20AND%20SRC:MED&resulttype=core&format=json

25 December 2019

issue

31

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17297466%20AND%20SRC:MED&resulttype=core&format=json

25 December 2019

page(s)

4469-4477

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17297466%20AND%20SRC:MED&resulttype=core&format=json

https://scigraph.springernature.com/pub.10.1038/sj.onc.1210243

25 December 2019

exact match

0 references

cites work

Identification of a gene that reverses the immortal phenotype of a subset of cells and is a member of a novel family of transcription factor-like genes

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210243

Cyclin-dependent kinase inhibitors: cancer killers to neuronal guardians

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210243

Cdk4 deficiency inhibits skin tumor development but does not affect normal keratinocyte proliferation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210243

Targeted disruption of CDK4 delays cell cycle entry with enhanced p27(Kip1) activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210243

ES cells do not activate p53-dependent stress responses and undergo p53-independent apoptosis in response to DNA damage

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210243

7 January 2021

Mouse models of cell cycle regulators: new paradigms

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210243

7 January 2021

Cdc2-cyclin E complexes regulate the G1/S phase transition

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210243

7 January 2021

Cyclin dependent kinase inhibitors prevent apoptosis of postmitotic mouse motoneurons

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210243

7 January 2021

Cdk2 knockout mice are viable

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210243

7 January 2021

Cdk2 and Cdk4 cooperatively control the expression of Cdc2

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210243

7 January 2021

Combined loss of Cdk2 and Cdk4 results in embryonic lethality and Rb hypophosphorylation

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210243

7 January 2021

Mice with bad ends: mouse models for the study of telomeres and telomerase in cancer and aging

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210243

7 January 2021

Cyclin B2-null mice develop normally and are fertile whereas cyclin B1-null mice die in utero

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210243

7 January 2021

Signalling, cell cycle and pluripotency in embryonic stem cells

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210243

7 January 2021

Combined depletion of cell cycle and transcriptional cyclin-dependent kinase activities induces apoptosis in cancer cells

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210243

7 January 2021

Senescent cells, tumor suppression, and organismal aging: good citizens, bad neighbors

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210243

7 January 2021

Tumour biology: senescence in premalignant tumours

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210243

7 January 2021

Ablation of the retinoblastoma gene family deregulates G(1) control causing immortalization and increased cell turnover under growth-restricting conditions

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210243

7 January 2021

What has senescence got to do with cancer?

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210243

7 January 2021

Inhibition of cell proliferation and cell cycle progression by specific inhibition of basal JNK activity: evidence that mitotic Bcl-2 phosphorylation is JNK-independent

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210243

7 January 2021

Mice lacking cyclin D1 are small and show defects in eye and mammary gland development.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210243

7 January 2021

A syndrome of multiorgan hyperplasia with features of gigantism, tumorigenesis, and female sterility in p27(Kip1)-deficient mice

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210243

7 January 2021

Human cyclin A is required for mitosis until mid prophase

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210243

7 January 2021

Cyclin E ablation in the mouse

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210243

7 January 2021

A link between cell cycle and cell death: Bax and Bcl-2 modulate Cdk2 activation during thymocyte apoptosis.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210243

7 January 2021

The cyclin-dependent kinase Cdk2 regulates thymocyte apoptosis

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210243

7 January 2021

Differential contributions of ERK and PI3-kinase to the regulation of cyclin D1 expression and to the control of the G1/S transition in mouse embryonic stem cells

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210243

7 January 2021

Tumor suppression at the mouse INK4a locus mediated by the alternative reading frame product p19ARF

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210243

7 January 2021

Senescence and cell cycle control

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210243

7 January 2021

Enhanced growth of mice lacking the cyclin-dependent kinase inhibitor function of p27(Kip1).

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210243

7 January 2021

Retinoblastoma tumor suppressor: where cancer meets the cell cycle

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210243

7 January 2021

Inhibition of basal and mitogen-stimulated pancreatic cancer cell growth by cyclin D1 antisense is associated with loss of tumorigenicity and potentiation of cytotoxicity to cisplatinum

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210243

7 January 2021

Mouse development and cell proliferation in the absence of D-cyclins.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210243

7 January 2021

Cyclin D1-dependent kinase activity in murine development and mammary tumorigenesis

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210243

7 January 2021

Cyclin D1 is required for transformation by activated Neu and is induced through an E2F-dependent signaling pathway

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210243

7 January 2021

Sensing, signaling, and responding to DNA damage: organization of the checkpoint pathways in mammalian cells

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210243

7 January 2021

Mammalian cells cycle without the D-type cyclin-dependent kinases Cdk4 and Cdk6

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210243

7 January 2021

Cdk2 is dispensable for cell cycle inhibition and tumor suppression mediated by p27(Kip1) and p21(Cip1).

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210243

7 January 2021

Activation of cyclin A-dependent protein kinases during apoptosis

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210243

7 January 2021

Lack of cyclin-dependent kinase 4 inhibits c-myc tumorigenic activities in epithelial tissues

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210243

7 January 2021

Control of pRB phosphorylation

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210243

7 January 2021

Cellular lifespan and senescence signaling in embryonic stem cells

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210243

7 January 2021

A lentiviral RNAi library for human and mouse genes applied to an arrayed viral high-content screen

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210243

7 January 2021

Cyclin-dependent kinases: engines, clocks, and microprocessors

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210243

7 January 2021

The cyclin A1-CDK2 complex regulates DNA double-strand break repair.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210243

7 January 2021

Delayed early embryonic lethality following disruption of the murine cyclin A2 gene.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210243

7 January 2021

Mice lacking p27(Kip1) display increased body size, multiple organ hyperplasia, retinal dysplasia, and pituitary tumors

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210243

7 January 2021

Cyclin-dependent kinase 2 is essential for meiosis but not for mitotic cell division in mice.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210243

7 January 2021

Wagging the dogma; tissue-specific cell cycle control in the mouse embryo.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210243

7 January 2021

Cyclins E1 and E2 are required for endoreplication in placental trophoblast giant cells

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210243

7 January 2021

Discovery and evaluation of dual CDK1 and CDK2 inhibitors

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210243

7 January 2021

Genetic evidence for functional dependency of p18Ink4c on Cdk4.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210243

7 January 2021

Dependence of cisplatin-induced cell death in vitro and in vivo on cyclin-dependent kinase 2

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210243

7 January 2021

p53-independent DNA repair and cell cycle arrest in embryonic stem cells

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210243

7 January 2021

Loss of Cdk4 expression causes insulin-deficient diabetes and Cdk4 activation results in beta-islet cell hyperplasia

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210243

7 January 2021

Cyclin-dependent kinase 4 expression is essential for neu-induced breast tumorigenesis

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210243

7 January 2021

(R)-roscovitine (CYC202, Seliciclib) sensitizes SH-SY5Y neuroblastoma cells to nutlin-3-induced apoptosis

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210243

7 January 2021

Reduced skin tumor development in cyclin D1-deficient mice highlights the oncogenic ras pathway in vivo

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210243

7 January 2021

Cyclin-dependent kinase inhibitors enhance the resolution of inflammation by promoting inflammatory cell apoptosis

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210243

7 January 2021

Identification of BTG2, an antiproliferative p53-dependent component of the DNA damage cellular response pathway

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210243

7 January 2021

Targeted disruption of the three Rb-related genes leads to loss of G(1) control and immortalization

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210243

7 January 2021

Cyclins and CDKS in development and cancer: lessons from genetically modified mice

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210243

7 January 2021

Loss of p16Ink4a with retention of p19Arf predisposes mice to tumorigenesis

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210243

7 January 2021

CDK inhibitors: positive and negative regulators of G1-phase progression

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210243

7 January 2021

Cyclin D1 provides a link between development and oncogenesis in the retina and breast.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210243

7 January 2021

E2F1-induced apoptosis: turning killers into therapeutics

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210243

7 January 2021

Pluripotent cell division cycles are driven by ectopic Cdk2, cyclin A/E and E2F activities

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210243

7 January 2021

Proliferation of cancer cells despite CDK2 inhibition.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210243

7 January 2021

p53 mutant mice that display early ageing-associated phenotypes

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210243

7 January 2021

Live or let die: the cell's response to p53

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210243

7 January 2021

Cellular mortality to immortalization: mortalin.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210243

7 January 2021

Phenol red reduces ROSC mediated cell cycle arrest and apoptosis in human MCF-7 cells

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210243

7 January 2021

Activation of Cdk2 is a requirement for antigen-mediated thymic negative selection

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210243

7 January 2021

Specific protection against breast cancers by cyclin D1 ablation

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210243

7 January 2021

Requirement for CDK4 kinase function in breast cancer

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210243

7 January 2021

Cdk4 disruption renders primary mouse cells resistant to oncogenic transformation, leading to Arf/p53-independent senescence

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210243

7 January 2021

Identifiers

DOI

10.1038/SJ.ONC.1210243

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17297466%20AND%20SRC:MED&resulttype=core&format=json

25 December 2019

1 reference